PATLY.AIApplication
16280913 · QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION
Filed 2019-02-20 · Granted · Patent 10793894 (2020-10-06) The official file ↗The patent and its PDF ↗ · Art unit 1655 · Examiner Ralph J Gitomer Easy · CPC C12Q 1/40 · BIOMARIN PHARMACEUTICAL INC. · Jones Day for BioMarin
Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
12.0 mo
to disposition 19.5 mo
Statutes raised
DP
1 actions read